Murine vesicular monoamine transporter 2: Molecular cloning and genomic structure

Molecular Brain Research

Volumn 49, Issue 1-2, 1997, Pages 7-14

  Takahashi, Nobuyuki ^a   Uhl, George ^a  

^a Molecular Neurobiology   (United States)

Author keywords

Amphetamine; cDNA; Gene; N Methyl 1,2,3,6 tetrahydropyridine (MPTP); Promoter; Vesicular monoamine transporter (VMAT2)

Indexed keywords

CARRIER PROTEIN; COMPLEMENTARY DNA; MONOAMINE; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CONSENSUS SEQUENCE; CYCLIC AMP RESPONSIVE ELEMENT; DNA RESPONSIVE ELEMENT; DNA STRUCTURE; EXON; GENE STRUCTURE; HUMAN; MOLECULAR CLONING; MONOAMINE RELEASE; MOUSE; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; RAT; SEQUENCE HOMOLOGY; TATA BOX; TRANSCRIPTION INITIATION; TRANSLATION INITIATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BRAIN; BRAIN STEM; CLONING, MOLECULAR; CONSERVED SEQUENCE; DNA, COMPLEMENTARY; EXONS; HUMANS; INTRONS; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; NEUROTRANSMITTER AGENTS; OPEN READING FRAMES; RATS; RECOMBINANT PROTEINS; REGULATORY SEQUENCES, NUCLEIC ACID; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION, GENETIC; VESICULAR BIOGENIC AMINE TRANSPORT PROTEINS; VESICULAR MONOAMINE TRANSPORT PROTEINS;

ANIMALIA; MURINAE;

EID: 0030697880     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00116-2     Document Type: Article

References (45)

1. Burns R.S., Chiueh C.C., Markey S.P., Ebert M.H., Jacobowitz D.M., Kopin I.J. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA. 80:1983;4546-4550.
2. Carcamo J., Maldonado E., Cortes P., Ahn M.-H., Ha I., Kasai Y., Flint J., Reinberg D. A TATA-like sequence located downstream of the transcription initiation site is required for expression of an RNA polymerase II transcribed gene. Genes Dev. 4:1990;1611-1622.
3. Desnos C., Laran M.-P., Scherman D. Regulation of the chromaffin granule catecholamine transporter in cultured bovine adrenal medullary cells: stimulus-biosynthesis coupling. J. Neurochem. 59:1992;2105-2112.
4. Donovan D.M., Vandenbergh D.J., Perry M.P., Bird G.S., Ingersoll R., Nanthakumar E., Uhl G.R. Human and mouse dopamine transporter genes: conservation of 5′-flanking sequence elements and gene structures. Mol. Brain Res. 30:1995;327-335.
5. Dynan W.S. Promoters for housekeeping genes. Trends Genet. 2:1986;196-197.
6. Erickson J.D., Eiden L.E. Functional identification and molecular cloning of a human brain vesicle monoamine transporter. J. Neurochem. 61:1993;2314-2317.
7. Erickson J.D., Eiden L.E., Hoffman B.J. Expression cloning of a reserpine-sensitive vesicular monoamine transporter. Proc. Natl. Acad. Sci. USA. 89:1992;10993-10997.
8. Forgac M. Structure and function of vacuolar class of ATP-driven proton pumps. Physiol. Rev. 69:1989;765-796.
9. Ghosh D. Status of the transcription factors database (TFD). Nucleic Acids Res. 21:1993;3117-3118.
10. Giros B., Caron M.C. Molecular characterization of the dopamine transporter. Trends Pharmacol. Sci. 14:1993;43-49.
11. Gonzalez A.M., Walther D., Pazos A., Uhl G.R. Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile. Mol. Brain Res. 22:1994;219-226.
12. Heikkila R.E., Manzino L., Cabbat F.S., Duvoisin R.C. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature. 311:1984;467-469.
13. Henry J.-P., Botton D., Sagne C., Isambert M.-F., Desnos C., Blanchard V., Raisman-Vozari R., Krejci E., Massoulie J., Gasnier B. Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules. J. Exp. Biol. 196:1994;251-262.
14. Hirzmann J., Luo D., Hahnen J., Hobom G. Determination of messenger RNA 5′-end by reverse transcription of the cap structure. Nucleic Acids Res. 21:1993;3597-3598.
15. Ishiguro H., Kim K.T., Joh T.H., Kim K.-S. Neuron-specific expression of the human dopamine β-hydroxylase gene requires both the cAMP-response element and a silencer. J. Biol. Chem. 268:1993;17987-17994.
16. Johnson R.G. Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport. Physiol. Rev. 68:1988;232-307.
17. Kanner B.I., Schuldiner S. Mechanism of transport and storage of neurotransmitters. CRC Crit. Rev. Biochem. 22:1987;1-38.
18. +: nonneuronal COS cells expressing dopamine transporter cDNA. Ann. Neurol. 32:1992;109-111.
19. Krejci E., Gasnier B., Botton D., Isambert M.-F., Sagné C., Gagnon J., Massoulié J., Henry J.-P. Expression and regulation of the bovine vesicular monoamine transporter gene. FEBS Lett. 335:1993;27-32.
20. Lam D.M.-K., Fei J., Zhang X.-Y., Tam A.C.W., Zhu L.-H., Huang F., King S.C., Guo L.-H. Molecular cloning and structure of the human (GABATHG) GABA transporter gene. Mol. Brain Res. 19:1993;227-232.
21. Langston J.M., Ballard P. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 219:1983;979-980.
22. Lesch K.-P., Balling U., Gross J., Strauss K., Wolozin B.L., Murphy D.L., Riederer P. Organization of the human serotonin transporter gene. J. Neural Transm. 95:1994;157-162.
23. Liu Q.-R., Mandiyan S., Nelson H., Nelson N. A family of genes encoding neurotransmitter transporters. Proc. Natl. Acad. Sci. USA. 89:1992;6639-6643.
24. + toxicity. Mol. Brain Res. 25:1994;90-96.
25. + toxicity encodes a vesicular amine transporter. Cell. 70:1992;539-551.
26. Liu Y., Roghani A., Edwards R.H. Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. USA. 89:1992;9074-9078.
27. Maue R.A., Kraner S.D., Goodman R.H. Neuron-specific expression of the rat brain type II sodium channel gene is directed by upstream regulatory elements. Neuron. 4:1990;223-231.
28. Melikian H.E., Ramamoorthy S., Tate C.G., Blakely R.D. Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. J. Pharmacol. Exp. Ther. 50:1996;266-267.
29. Merickel A., Edwards R.H. Transport of histamine by vesicular monoamine t transporter-2. Neuropharmacology. 34:1995;1543-1547.
30. Minowa T., Minowa M.T., Mouradian M. Analysis of the promoter region of the rat D2 dopamine receptor gene. Biochemistry. 31:1992;8389-8396.
31. Mori N., Stein R., Sigmund O., Anderson D.J. A cell type-preferred silencer element that controls the neural-specific expression of the SCG10 gene. Neuron. 4:1990;583-594.
32. Nakanishi N., Onozawa S., Matsumoto R., Hasegawa H., Yamada S. Cyclic AMP-dependant modulation of vesicular monoamine transport in pheochromocytoma cells. J. Neurochem. 64:1995;600-607.
33. Njus D., Kelley P.M., Harnadek G.J. Biogenetics of secretory vesicles. Biochem. Biophys. Acta. 853:1986;237-265.
34. Peter D., Liu Y., Sternini C., de Giorgio R., Brecha N., Edwards R.H. Differential expression of two vesicular monoamine transporters. J. Neurosci. 15:1995;6179-6188.
35. Pifl C., Giros B., Caron M.G. Dopamine transporter expression confers cytotoxicity to low doses of the parkinsonism-inducing neurotoxin 1-methyl-4-phenylpyridinium. J. Neurosci. 13:1993;4246-4253.
36. Roghani A., Feldman J., Kohan S.A., Shirzadi A., Gundersen C.B., Brecha N., Edwards R.H. Molecular cloning of a putative vesicular transporter for acetylcholine. Proc. Natl. Acad. Sci. USA. 91:1994;10620-10624.
37. Rudnick G., Wall S.C. The molecular mechanism of 'ecstasy' [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release. Proc. Natl. Acad. Sci. USA. 89:1992;1817-1821.
38. Seiden L.S., Sabol K.E., Ricaurte G.A. Amphetamine: effects on catecholamine systems and behavior. Annu. Rev. Pharmacol. Toxicol. 32:1993;639-677.
39. Sulzer D., Rayport S. Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron. 5:1990;797-808.
40. Surratt C.K., Persico A.M., Yang X.-D., Edger S.R., Bird G.S., Hawkins A.L., Griffin C.A., Ethylin X.L., Jabs W., Uhl G.R. A human synaptic vesicle monoamine transporter cDNA predicts posttranslational modifications, reveals chromosome 10 gene localization and identifies TaqI RFLPs. FEBS Lett. 318:1993;325-330.
41. Surratt C.K., Wang J.-B., Yuhasz S., Amzel M., Moo Kwon H., Handler J.S., Uhl G.R. Sodium- and chloride-dependent transporters in brain, kidney, and gut: lessons from complementary DNA and structure studies. Curr. Opin. Nephrol. Hypertens. 2:1993;744-760.
42. Tien T., Amara S.G. N-linked oligosaccharides are required for cell surface expression of the norepinephrine transporter but do not influence substrate or inhibitor recognition. J. Neurochem. 67:1996;645-655.
43. Uhl G.R. Neurotransmitter transporters (plus): a promising new gene family. Trends Neurosci. 15:1992;265-268.
44. Weihe E., Schäfer M.K.-H., Erickson J.D., Eiden L.E. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J. Mol. Neurosci. 5:1994;149-164.
45. Zhou Q.-Y., Li C., Civelli O. Characterization of gene organization and promoter region of the rat dopamine D1 receptor gene. J. Neurochem. 59:1992;1875-1883.